Imaging of pulmonary viral pneumonia

T Franquet - Radiology, 2011 - pubs.rsna.org
Imaging and clinical manifestations of viral pneumonia are protean and not reliably
predictive of its origin. All patients with neutropenic fever and normal findings at chest …

The immune control and cell-to-cell spread of human T-lymphotropic virus type 1

CRM Bangham - Journal of General Virology, 2003 - microbiologyresearch.org
Human T-lymphotropic virus type 1 (HTLV-1) varies little in sequence compared with human
immunodeficiency virus type 1 (HIV) and it is difficult to detect HTLV-1 mRNA, proteins or …

The HTLV-1 neurological complex

AQC Araujo, MTT Silva - The Lancet Neurology, 2006 - thelancet.com
Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20 million
people worldwide and causes immune-mediated diseases of the nervous system. The …

5′-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo

T Koiwa, A Hamano-Usami, T Ishida… - Journal of …, 2002 - Am Soc Microbiol
CpG methylation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat
(LTR) has been implicated in proviral latency, but there is presently little information …

[HTML][HTML] 40 years of the human T-cell leukemia virus: past, present, and future

Y Tagaya, M Matsuoka, R Gallo - F1000Research, 2019 - ncbi.nlm.nih.gov
It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

[HTML][HTML] Updates on HTLV-1 uveitis

K Kamoi, T Watanabe, K Uchimaru, A Okayama, S Kato… - Viruses, 2022 - mdpi.com
HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated
disease. Although HU is considered to be the second-most frequent HTLV-1-associated …

[HTML][HTML] The nature of the HTLV-1 provirus in naturally infected individuals analyzed by the viral DNA-capture-seq approach

H Katsuya, S Islam, BJY Tan, J Ito, P Miyazato… - Cell Reports, 2019 - cell.com
The retrovirus human T-cell leukemia virus type 1 (HTLV-1) integrates into the host DNA,
achieves persistent infection, and induces human diseases. Here, we demonstrate that viral …

Dual targeting of transformed and untransformed HTLV-1–infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and …

M Watanabe, T Ohsugi, M Shoda, T Ishida, S Aizawa… - Blood, 2005 - ashpublications.org
Human T-cell leukemia virus type I (HTLV-1) causes adult T-cell leukemia (ATL), a fatal T-
cell leukemia resistant to chemotherapy, after more than 50 years of clinical latency from …

Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/γcnull Mice: Suppression by an Inhibitor against NF-κB

MZ Dewan, K Terashima, M Taruishi… - Journal of …, 2003 - Am Soc Microbiol
We established a novel experimental model for human T-cell leukemia virus type 1 (HTLV-1)-
induced tumor using NOD-SCID/γcnull (NOG) mice. This model is very useful for …

[HTML][HTML] DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation

JF Burrows, MJ McGrattan, A Rascle, M Humbert… - Journal of Biological …, 2004 - ASBMB
Previous studies have identified the DUB family of cytokine-regulated murine
deubiquitinating enzymes, which play a role in the control of cell proliferation and survival …